Influence of recent cannabis use on altered spectral entropy modulation and connectivity strength in patients with psychosis

Bachiller A, Lubeiro A, Diez A, Suazo V, Dominguez C, Blanco JA, Ayuso M, Hornero R, Poza J, Molina V (2014) Decreased entropy modulation of EEG response to novelty and relevance in schizophrenia during a P300 task. Eur Arch Psychiatry Clin Neurosci. https://doi.org/10.1007/s00406-014-0525-5

Article  PubMed  Google Scholar 

Cea-Canas B, Gomez-Pilar J, Nunez P, Rodriguez-Vazquez E, de Uribe N, Diez A, Perez-Escudero A, Molina V (2020) Connectivity strength of the EEG functional network in schizophrenia and bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 98:109801

Article  CAS  PubMed  Google Scholar 

Dehaene S, Kerszberg M, Changeux JP (1998) A neuronal model of a global workspace in effortful cognitive tasks. Proc Natl Acad Sci U S A 95(24):14529–14534

Article  CAS  PubMed  PubMed Central  Google Scholar 

Di Forti M, Quattrone D, Freeman TP, Tripoli G, Gayer-Anderson C, Quigley H, Rodriguez V, Jongsma HE, Ferraro L, La Cascia C, La Barbera D, Tarricone I, Berardi D, Szoke A, Arango C, Tortelli A, Velthorst E, Bernardo M, Del-Ben CM, Menezes PR, Selten JP, Jones PB, Kirkbride JB, Rutten BP, de Haan L, Sham PC, van Os J, Lewis CM, Lynskey M, Morgan C, Murray RM, Group, E-G.W (2019) The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study. Lancet Psychiatry 6(5):427–436

Diez A, Gomez-Pilar J, Poza J, Beno-Ruiz-de-la-Sierra R, Fernandez-Linsenbarth I, Recio-Barbero M, Nunez P, Holgado-Madera P, Molina V (2024) Functional network properties in schizophrenia and bipolar disorder assessed with high-density electroencephalography. Prog Neuropsychopharmacol Biol Psychiatry 129:110902

Article  CAS  PubMed  Google Scholar 

Diez A, Suazo V, Casado P, Martin-Loeches M, Molina V (2013) Spatial distribution and cognitive correlates of gamma noise power in schizophrenia. Psychol Med 43(6):1175–1186

Article  CAS  PubMed  Google Scholar 

Duff BJ, Macritchie KA, Moorhead TW, Lawrie SM, Blackwood DH (2013) Human brain imaging studies of DISC1 in schizophrenia, bipolar disorder and depression: a systematic review. Schizophr Res 147(1):1–13

Article  PubMed  Google Scholar 

Farkas I, Kallo I, Deli L, Vida B, Hrabovszky E, Fekete C, Moenter SM, Watanabe M, Liposits Z (2010) Retrograde endocannabinoid signaling reduces GABAergic synaptic transmission to gonadotropin-releasing hormone neurons. Endocrinology 151(12):5818–5829

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gomez-Pilar J, de Luis-Garcia R, Lubeiro A, de Uribe N, Poza J, Nunez P, Ayuso M, Hornero R, Molina V (2018) Deficits of entropy modulation in schizophrenia are predicted by functional connectivity strength in the theta band and structural clustering. Neuroimage Clin 18:382–389

Article  PubMed  PubMed Central  Google Scholar 

Gonzalez-Burgos G, Lewis DA (2012) NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia. Schizophr Bull 38(5):950–957

Article  PubMed  PubMed Central  Google Scholar 

Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13(2):261–276

Article  CAS  PubMed  Google Scholar 

Keefe RS, Goldberg TE, Harvey PD, Gold JM, Poe MP, Coughenour L (2004) The brief assessment of cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr Res 68(2–3):283–297

Article  PubMed  Google Scholar 

Kirkpatrick B, Strauss GP, Nguyen L, Fischer BA, Daniel DG, Cienfuegos A, Marder SR (2011) The brief negative symptom scale: psychometric properties. Schizophr Bull 37(2):300–305

Article  PubMed  Google Scholar 

Kuepper R, Ceccarini J, Lataster J, van Os J, van Kroonenburgh M, van Gerven JM, Marcelis M, Van Laere K, Henquet C (2013) Delta-9-tetrahydrocannabinol-induced dopamine release as a function of psychosis risk: 18F-fallypride positron emission tomography study. PLoS One 8(7):e70378

Article  CAS  PubMed  PubMed Central  Google Scholar 

Manoach DS (2003) Prefrontal cortex dysfunction during working memory performance in schizophrenia: reconciling discrepant findings. Schizophr Res 60(2–3):285–298

Article  PubMed  Google Scholar 

McLoughlin BC, Pushpa-Rajah JA, Gillies D, Rathbone J, Variend H, Kalakouti E, Kyprianou K (2014) Cannabis and schizophrenia. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD004837.pub3

Article  PubMed  PubMed Central  Google Scholar 

Metzner C, Maki-Marttunen T, Karni G, McMahon-Cole H, Steuber V (2022) The effect of alterations of schizophrenia-associated genes on gamma band oscillations. Schizophrenia (Heidelb) 8(1):46

Article  CAS  PubMed  Google Scholar 

Miller AP, Baranger DAA, Paul SE, Garavan H, Mackey S, Tapert SF, LeBlanc KH, Agrawal A, Bogdan R (2024) Neuroanatomical variability associated with early substance use initiation: results from the ABCD Study. medRxiv

Molina V, Bachiller A, Gomez-Pilar J, Lubeiro A, Hornero R, Cea-Canas B, Valcarcel C, Haidar MK, Poza J (2018) Deficit of entropy modulation of the EEG in schizophrenia associated to cognitive performance and symptoms. A replication study. Schizophr Res 195:334–342

Article  PubMed  Google Scholar 

Molina V, Lubeiro A, de Luis Garcia R, Gomez-Pilar J, Martin-Santiago O, Iglesias-Tejedor M, Holgado-Madera P, Segarra-Echeverria R, Recio-Barbero M, Nunez P, Haidar MK, Fernandez-Sevillano J, Sanz-Fuentenebro J (2020) Deficits of entropy modulation of the EEG: a biomarker for altered function in schizophrenia and bipolar disorder? J Psychiatry Neurosci 45(3):190032

Google Scholar 

Reddy-Thootkur M, Kraguljac NV, Lahti AC (2022) The role of glutamate and GABA in cognitive dysfunction in schizophrenia and mood disorders - a systematic review of magnetic resonance spectroscopy studies. Schizophr Res 249:74–84

Article  CAS  PubMed  Google Scholar 

Rentzsch J, Stadtmann A, Montag C, Kunte H, Plockl D, Hellweg R, Gallinat J, Kronenberg G, Jockers-Scherubl MC (2016) Attentional dysfunction in abstinent long-term cannabis users with and without schizophrenia. Eur Arch Psychiatry Clin Neurosci 266(5):409–421

Article  PubMed  Google Scholar 

Sherif M, Radhakrishnan R, D’Souza DC, Ranganathan M (2016) Human laboratory studies on cannabinoids and psychosis. Biol Psychiatry 79(7):526–538

Article  CAS  PubMed  Google Scholar 

Sherif MA, Cortes-Briones JA, Ranganathan M, Skosnik PD (2018) Cannabinoid-glutamate interactions and neural oscillations: implications for psychosis. Eur J Neurosci 48(8):2890–2902

Article  PubMed  Google Scholar 

Skosnik PD, D’Souza DC, Steinmetz AB, Edwards CR, Vollmer JM, Hetrick WP, O’Donnell BF (2012) The effect of chronic cannabinoids on broadband EEG neural oscillations in humans. Neuropsychopharmacology 37(10):2184–2193

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sun Y, Farzan F, Barr MS, Kirihara K, Fitzgerald PB, Light GA, Daskalakis ZJ (2011) gamma oscillations in schizophrenia: mechanisms and clinical significance. Brain Res 1413:98–114

Article  CAS  PubMed  Google Scholar 

Tandon R, Nasrallah H, Akbarian S, Carpenter WT Jr, DeLisi LE, Gaebel W, Green MF, Gur RE, Heckers S, Kane JM, Malaspina D, Meyer-Lindenberg A, Murray R, Owen M, Smoller JW, Yassin W, Keshavan M (2024) The schizophrenia syndrome, circa 2024: What we know and how that informs its nature. Schizophr Res 264:1–28

Article  PubMed  Google Scholar 

Vahed N, Saberizafarghandi MB, Bashirpour H, Ahmadkhaniha HR, Arezoomandan R (2024) Effect of cannabis on brain activity in males: quantitative electroencephalography and its relationship with duration, dosage, and age of onset. J Clin Neurosci 132:110982

Article  PubMed  Google Scholar 

Comments (0)

No login
gif